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1. Introduction 
Recent data sho_w that thyroid membrane has 
receptors which interact with thyroglobulin. The latter 
can significantly inhibit thyrotropin binding to thyroid 
plasma membrane [ 1,2]. The possible correlation of 
this effect to a reduction of adenylate cyclase activity 
is controversial [3,4]. Here we describe the effect of 
pre-incubation with human native thyroglobulin on 
TSH-stimulated cyclic AMP accumulation i human 
cultured thyroid cells. These data show that native 
thyroglobulin reversibly inhibits the response to TSH. 
2. Materials and methods 
Thyroid cells were prepared from the counterside 
lobe obtained uring thyroidectomy, in cases of 
monofocal cancer, by mechanical dispersion after 
trypsinization as in [5]. Dispersed cells suspended in
McCoy’s 5a medium containing 20% foetal calf serum 
(FCS) were seeded in Linbro multi-well plates and 
kept in culture for 7 days. Adrenocortical cells were 
isolated from human adrenal gland obtained uring 
nephrectomy by mechanical dispersion after tryp- 
sinization with some modifications of the method 
used for thyroid cells and kept in the same culture 
medium containing synthetic l-24 ACTH (3.5 PM) 
for 7 days. The study of adenylate cyclase-CAMP 
system was done in Krebs-Ringer bicarbonate (KRB) 
buffer, containing 0.6 mM 3-isobutyl-l-methyl- 
xanthine (IMX), 10 mM glucose and 2 g/l human 
serum albumin (HSA) according to [5]. Each experi- 
ment was performed with triplicate incubations and 
repeated 3times. 
Human thyroglobulin was purified from saline 
extracts of normal thyroid slices by 1.4-I .8 M 
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ammonium sulphate precipitation [6] followed by gel 
filtration on Sephacryl S-300 immediately before use 
on cultured cells; the 19 S peak was diluted to appro- 
priate concentrations. Protein concentration was 
measured by Azso (el cm - ‘% 10.0). Intracellular accu- 
mulation of CAMP was measured in triplicate in the 
freezed-dried 2000 X g supernatant of the ethanol- 
treated homogenate, by saturation analysis using a 
cytosol protein purified from bovine adrenal cortices 
[7]. The DNA content was measured in the pellet by 
a fluorimetric method [8] after complete xtraction 
of lipids. Statistical analysis was performed by one- 
way analysis of variance. 
The bovine TSH (bTSH; batch no. 53/l 1) was 
generously supplied by National Institute for Biolog- 
ical Standard and Control, Holly Hill, London; CAMP 
and IMX were purchased from Sigma (St Louis, MO); 
[2,8-3H]adenosine 3’,5’-cyclic phosphate ammonium 
salt from the Radiochemical Centre (Amersham); 
synthetic l-24 ACTH (Synacthen@) from Ciba-Geigy 
(Basel); Sephacryl S-300 from Pharmacia (Uppsala); 
McCoy’s 5a medium and foetal calf serum from 
Gibco (Grand Island, NY); culture multi-well plates 
from Linbro, Flow Labs. (CN); porcine trypsin and 
all other reagents qalytical grade from Merck 
(Darmstadt). 
3. Results 
Cultured thyroid cells maintained the capacity to 
respond to bTSH, measured as CAMP intracellular 
accumulation, from a dose as low as 0.1 mu/ml. A 
dose-dependent i crease in CAMP intracellular levels 
was observed after 30 min incubation up to 2.5 
mu/ml of bTSH (mean + SDM: 9.27 + 0.38 pmol 
cAMP/pg DNA vs basal values: 0.67 f 0.08 pmol 
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Fig.1. Effect of different preincubation times with native 
human thyroglobulin on CAMP accumulation induced by 
bTSH in human cultured thyrocytes. About 1.5 X 10’ thyro- 
cytes were preincubated in triplicate varying from 15-240 
min at 37’C in McCoy’s 5a medium supplemented with 20% 
FCS and 1.5 NM thyroglobuhn. At the end of preincubation 
cells were stimulated in KRB buffer @H 7.4) containing 
2.0 g/l glucose, 2.0 g/l HSA and 0.6 mM IMX_at 37°C with 
2.5 mu/ml of bTSH. Results are expressed as pmol cAMP/cg 
DNA, vertical bars represent standard deviation of mean. 
cAMP/pg DNA). Human native thyroglobulin up to 
4 I.IM had no effect on CAMP accumulation during 
30-l 20 min incubation (mean f SDM: 0.65 f 0.7 
pmol cAMP/pg DNA). 
Pretreatment with human native thyroglobulin 
(1.5 PM) had an inhibitory effect on bTSH-stimulated 
CAMP accumulation as shown in fig.1. Inhibition 
appeared after 60 min incubation and reached a
maximum of -42% of the basal evel after 120 min 
and decreased after 4 h. When cultured thyroid cells 
were pretreated with different doses of human native 
thyroglobulin (from 0.1-4.0 PM) for 120 min, a 
dose-dependent reduction in the subsequent bTSH 
stimulation of CAMP formation was observed from 
1 .O PM thyroglobulin (fig.2). To verify that the 
inhibitory effect of native thyroglobulin was not the 
consequence of a permanent reduction in thyroid 
function, experiments were performed to determine 
whether the action of thyroglobulin was reversed by 
washing (fig.3). Thyroid cells preincubated for 
120 min with thyroglobuhn (1.5 PM), were washed 
3 times with fresh medium and subsequently stimu- 
lated with bTSH (2.5 mu/ml) at different times after 
the removal of thyroglobulin (15-l 20 min). A nor- 
mal response appeared after 60-90 min. 
The inhibitory effect of thyroglobulin on bTSH 
response of thyroid cells appeared to be specific. In 
Fii.2. Effect of 120 min preincubation with native human 
thyroglobulin on CAMP accumulation induced by bTSH in 
human cultured thyrocytes. About 1.5 x 10s thyrocytes 
were preincubated in triplicate at 3?C in McCoy’s 5a 
medium supplemented with 20% FCS, in presence of thyro- 
globulin at 0.1-4 PM. At the end of preincubation cells were 
stimulated with bTSH as in fq.1. Results are expressed as 
pmol CAMP/M DNA, vertical bars represent standard devia- 
tion of mean. 
fact, pre-treatment with human native thyroglobulin 
of human cultured adrenocortical cells did not reduce 
the increase of CAMP intracellular levels evoked by 
3$l min exposure to 10 &I synthetic 1-24 ACTH 
(not shown). 
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Fii.3. Effect of bTSH on CAMP accumulation in human cul- 
tured thyrocytes preincubated with human thyroglobuhn for 
120 min and then without thyroglobulin at different times. 
About 1.5 X lo* thyrocytes were preincubated in triplicate 
for 120 mm at 37’C in McCoy’s 5a medium supplemented 
wi.th 20% FCS and 1.5 J.IM human thyroglobuhn. Thyro- 
globulin was then removed by washing and cells were stimu- 
lated with bTSH,as in t&.1,15-120 mjn after the removal 
of thyroglobulin. Results are expressed as pmol cAMP/Lcg 
DNA, vertical bars represent standard deviation of mean. 
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4. Discussion 
These findings con&m that human native thyro- 
globulin, up to 4 FM, is ineffective in modifying the 
adenyfate ~ycla~-cAMPsystem of intact thyroid cells 
as observed in subcehular f actions [4]. However, pre- 
treatment of human cultured thyroid cells with 
homologous thyroglobulin for 31 h reduces the 
thyratropininduced CAMP intracellular accumula- 
tion. This inhibition seems to be specific in view of 
the fact that thyroglobulin pretreatment of other 
endocrine cells as human cultured adrenocartical ones 
do not modify the response to ACTH, Moreover, the 
inhibitory effect appears to be reversible, differently 
from that observed for thyro~ob~~n binding to 
thyroid plasma membrane [2]. 
The thyraglobulin inhibitory dose effective in 
thyroid cells appear >lO-foId higher than that found 
effective in the plasma membrane binding [l-3]. 
However, it is necessary to point out that the two 
systems are not comparable. In fact, labelled thyra- 
globulin binding to thyroid cell surface can not be 
studied in cultured thyroid cells in view of its inter- 
nalization through an endocytotic process which is 
thyrotropin- and ~AMPde~nd~nt (unpubli~ed). 
Even if the inhibitor dose of human thyro~obu~ 
is much higher than its circulating levels in normal 
subjects, our results uggest that it may play a role 
in modulating the in vivo response to thyrotrapin 
when the release is increased as in Graves’ disease and 
thyroid carcinoma. 
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